Companies: 10,795·Total market cap: $144.5T
Grifols, S.A.

Grifols, S.A.

GRFSNASDAQHealthcare● Active
$7.33
$-0.31(-4.06%)
Market Cap$6.2B
P/E Ratio
52W High$11.14
52W Low$7.35

Grifols, S.A. (GRFS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GRFS · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$824.6M -17.6% vs prior year
FY · as of Dec 31, 2025 · Reported in EUR
Cash & Cash Equiv. (CCE)
$824.6M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-17.6%
vs prior fiscal year
Latest Quarter
$702.7M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$824.6MCash on Hand
Total Debt$8.74BTotal Debt
Net Cash / Net Debt−$7.92BNet Debt Position
Cash vs Debt Ratio
Cash 9%Debt 91%

Grifols, S.A. carries a net debt position of $7.92B. Total debt ($8.74B) exceeds cash on hand ($824.6M). Grifols, S.A. cash vs debt ratio: 9% cash / 91% debt.

Net Cash = Cash & ST Investments − Total Debt$824.6M$8.74B = −$7.92B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
GRFS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$824.6M-17.6%
Dec 31, 2024$1.00B+54.9%
Dec 31, 2023$646.0M+11.3%
Dec 31, 2022$580.2M-78.4%
Dec 31, 2021$2.69B+354.7%
GRFS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Grifols, S.A.
Grifols, S.A.YOU
GRFS
$824.6M13.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Grifols, S.A. (GRFS) cash on hand as of December 31, 2025 is $824.6M, comprising $824.6M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Grifols, S.A. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Grifols, S.A. cash reserves or cash position.

Grifols, S.A. annual cash on hand history shows decreased -17.6% in 2025: decreased -17.6% in 2025. Grifols, S.A. cash reserves in 2025 reflect the company's capital allocation strategy.

Grifols, S.A. carries total debt of $8.74B against cash of $824.6M, resulting in a net debt position of -$7.92B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

GRFS cash on hand · 5 questions

As of December 31, 2025, Grifols, S.A. (GRFS) has $824,648,875 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $824,648,875 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $702,732,103. Data sourced from the annual 10-K filing via FMP.

GRFS cash on handGRFS cash reservesGRFS cash 2025how much cash does GRFS have

Source: FMP /balance-sheet-statement · US GAAP · Grifols, S.A. · Grifols, S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025